TNF and inflammatory bowel disease: Furthermore, we showed an interesting finding, by Spearman rank correlation, which highlighted a significant positive correlation between humoral and cellular immune responses in HCs and in IBD patients treated with aminosalicylates and vedolizumab but not in IBD patients treated with anti-TNFα inhibitors (Table 2).